Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Assembly Biosciences (ASMB) Operating Expenses: 2015-2025

Historic Operating Expenses for Assembly Biosciences (ASMB) over the last 9 years, with Sep 2025 value amounting to $21.7 million.

  • Assembly Biosciences' Operating Expenses rose 21.75% to $21.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $80.6 million, marking a year-over-year increase of 7.86%. This contributed to the annual value of $73.9 million for FY2024, which is 2.97% up from last year.
  • As of Q3 2025, Assembly Biosciences' Operating Expenses stood at $21.7 million, which was up 4.60% from $20.7 million recorded in Q2 2025.
  • Assembly Biosciences' Operating Expenses' 5-year high stood at $62.9 million during Q4 2021, with a 5-year trough of $15.0 million in Q3 2023.
  • Over the past 3 years, Assembly Biosciences' median Operating Expenses value was $19.4 million (recorded in 2025), while the average stood at $18.9 million.
  • Over the last 5 years, Assembly Biosciences' Operating Expenses had its largest YoY gain of 54.60% in 2021, and its largest YoY loss of 34.95% in 2021.
  • Assembly Biosciences' Operating Expenses (Quarterly) stood at $62.9 million in 2021, then reached $19.7 million in 2023, then dropped by 4.18% to $18.9 million in 2024, then grew by 21.75% to $21.7 million in 2025.
  • Its Operating Expenses was $21.7 million in Q3 2025, compared to $20.7 million in Q2 2025 and $19.4 million in Q1 2025.